Rhythm Pharmaceuticals buy BiotechBee
Start price
12.11.23
/
70%
€25.60
Target price
30.09.25
€35.00
Performance (%)
105.08%
End price
14.12.24
€52.50
Summary
This prediction ended on 14.12.24 with a price of €52.50. The BUY prediction by BiotechBee for Rhythm Pharmaceuticals saw massive gains of 105.08%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | 7.955% | 7.955% | 82.622% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to BiotechBee what are the pros and cons of Rhythm Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Buy mit Kursziel 35,0
In the thread Trading Rhythm Pharmaceuticals
Stopped prediction by BiotechBee for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€25.20
03.09.23
03.09.23
€35.00
31.12.25
31.12.25
-6.35%
05.09.23
05.09.23
Could be very worthwhile Investment >20% year
